444 Unveiling immune-related adverse events (irAEs) and symptom burden in melanoma patients on adjuvant immune checkpoint inhibitors (ICIs)
Main Authors: | Susan Peterson, Maria E Suarez-Almazor, Sanjay Shete, Sapna Patel, Cassian Yee, Adi Diab, Padmanee Sharma, Suhendan Ekmekcioglu, Rodabe Amaria, Isabella Glitza, Noha Abdel-Wahab, Michael K Wong, Jennifer McQuade, Michael A Davies, Salah-Eddine Bentebibel, Reham Abdel-Wahab, Hussain Tawbi, Bilal Anouti, Zaida Gonzales, Christine A Spillson, George P Baum, Joanna-Grace M Manzano, David Tweardy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
199 Quantitative and spatial characteristics of TIL in inflammatory neighborhoods of advanced melanoma tumors
by: Adi Diab, et al.
Published: (2023-11-01) -
1239 Major adverse cardiovascular events (MACE) in patients with melanoma receiving immune checkpoint inhibitors
by: Bo Zhao, et al.
Published: (2023-11-01) -
Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA)
by: Firas Kreidieh, et al.
Published: (2024-04-01) -
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
by: A Daban, et al.
Published: (2023-12-01) -
Pengaruh kecerunan ira terhadap kekuatan kayu /
by: 362638 Norazila Abdul Wahab
Published: (2006)